2024³â 12¿ù 25ÀÏ ¼ö¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

AI Redefined Gains Momentum with New Investment, Expands to Europe, and Appoints Industry Veterans to Key Leadership Roles

´º½ºÀÏÀÚ: 2023-12-30

MONTREAL--  AI Redefined, a pioneering force in human-AI collaboration technology, unveils key milestones showcasing exceptional growth and momentum. Following a successful Silicon Valley fundraising round, the Canadian company is set for success in the coming year. This is fueled by a new R&D facility in Paris, the cornerstone of its European operations, and the appointment of industry leaders Dr. Yves Lostanlen as General Manager and Bernard Slede as Senior Vice President of Business Development. The expansion aligns with the growing adoption of its award-winning Cogment™ technology.

Situated at Station F in the heart of the Paris AI technopole, the new studio serves as a strategic move to establish a presence in the European AI landscape. Beyond an office, this location aims to be an innovation and collaboration hub for developing new products and partnerships. The expansion includes a dedicated Paris-based R&D team, supporting AI Redefined's commitment to a pivotal role in the dynamic European AI ecosystem.

Leading AI Redefined in Europe is General Manager Dr. Yves Lostanlen, a seasoned industry veteran known for transformative leadership roles in major organizations such as Engie, Siemens, Element AI, government institutions, and academia. With deep and extensive knowledge in AI technologies, Dr. Lostanlen‘s strategic insights are evidenced through numerous keynote engagements and over 1200 citations for his articles. As a former board member of IEEE Communication Society and an Expert Advisor to prestigious entities like the European Commission and Council of Europe, his appointment reinforces AI Redefined’s commitment to attracting top talent to drive further innovation and growth.

About his new role, Dr. Lostanlen states: “Joining AI Redefined and the Cogment team at this exciting time, when human interaction is recognized as essential to AI advancements, is a tremendous opportunity. With Cogment‘s proven human-in-the-loop AI products, we offer a unique value proposition for deep-expertise industries historically challenged by AI-Human alignment. I am confident AI Redefined has what it takes to lead in today’s rapidly evolving AI landscape.”

In another strategic move, Bernard Slede joins AI Redefined as Senior Vice President of Business Development, bringing a proven track record from Intel, Dolby, and Vonage. Excited about joining AIR’s team, Slede notes, “Key markets such as aviation, defense, renewable energy, manufacturing and healthcare view AIR’s human-AI solutions as the missing piece to leverage their data. They’re eager to safely adopt and deploy AI through our trusted Cogment suite of Human-AI collaboration products.”

As AI Redefined gains momentum and prepares to announce key contracts, 2024 is anticipated as a year of exponential growth. The European expansion, coupled with the appointments of industry leaders and ongoing advancements by Cogment, reaffirms AI Redefined's commitment to shaping the future of human-AI collaboration.

About AI Redefined: AI Redefined is a multinational, award-winning, applied artificial intelligence research firm dedicated to better human-AI alignment. Founded in Montreal in 2018, the company focuses on developing Human-AI (RLHF) solutions that push the boundaries of what humans and AI can achieve in various industries, including aeronautics, renewable energy, manufacturing, and autonomous (e.g. human-machine teaming) systems.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Novotech Named a Fierce CRO Award Winner in the Excellence
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
The Next Gen of AI Awaits, GIGABYTE Sets the Benchmark for HPC at CES 2025
SpaceRISE Signs Concession Contract to Deliver Europe¡¯s IRIS©÷ Connectivity Network
Boomi Boosts Data Management Capabilities With Acquisition of Modern Data Integration Provider Rivery
Korean Robotaxi Startup Sonnet.AI Secures Level 4 Autonomous Shuttles Certification
KIOXIA NVMe SSD Cryptographic Module Achieves FIPS 140-3 Level 2 Validation

 

CHMP Recommends Approval of Galderma¡¯s Nemolizumab for Moderate-to-Se...
BrightPath Bio and Cellistic Announced Process Development and Manufac...
Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engi...
PDC*line Pharma Presents Primary Clinical Results From Phase I/II Tria...
Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Th...
Abu Dhabi¡¯s Technology Innovation Institute Inaugurates Open-Source A...
DNP Achieves Fine Pattern Resolution on EUV Lithography Photomasks for...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..